Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Hazel M Dockrell 
;
Helen McShane;
(2022)
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
EBioMedicine, 79.
103993-.
ISSN 2352-3964
DOI: 10.1016/j.ebiom.2022.103993
;
Helen McShane;
(2022)
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
EBioMedicine, 79.
103993-.
ISSN 2352-3964
DOI: 10.1016/j.ebiom.2022.103993
The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, prevent disease, or accelerate TB treatment. These vaccines are of different types, and designed to replace BCG, or to boost immunity following BCG vaccination. This viewpoint discusses why, when it has been possible to develop new vaccines for SARS-CoV-2 so quickly, it is taking so long to develop new tuberculosis vaccines.
-
picture_as_pdf - Dockrell_McShane_2022_Tuberculosis-vaccines-in-the-era.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 4.0
Downloads